Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
The global vaccine market was valued USD 78.21 Billion in 2023. It is expected to grow at a CAGR of 5.10% during the forecast period of 2024-2032 and attain a market value of USD 122.37 Billion by 2032. The market growth is driven by the increasing incidence of infectious diseases. Patents are focused on advanced technologies such as recombinant, toxoid, conjugate, and RNA.
The Global Vaccine Patent Landscape Report provides a comprehensive and in-depth analysis of the patents in this growing industry. The key sections captured in the report for vaccines include a thorough examination of the patent portfolios of key players, covering aspects such as the number of patents and types of technologies patented. It includes the latest trends, geographical distribution of patents, top IP player profiles, technological segmentation, and patent valuation associated with vaccines. The breakdown of patents by technical segments is provided, giving more clarity on the specific areas of innovation within vaccine technologies.
Patent Valuation Analysis
An evaluation and competitive benchmarking of key members of unique patent families are covered in the analysis for vaccine technologies. The important parameters have been taken into consideration including IP document, year of application, number of citations, time to expiry, and jurisdiction associated with vaccines.
Analysis of Patent Applications
A comprehensive summary of several patent applications which were filed across different jurisdictions for vaccine and their relative value are covered. The analysis will cover the capital in terms of innovation and innovation type.
Analysis of Granted Patents
Detailed analysis of the granted patents across different jurisdictions for vaccine and their relative value in the IP are covered in the final report.
A vaccine is a biological preparation that works to alert the immune system to identify and eliminate specific pathogens, like bacteria or viruses. It usually contains inactivated or weakened versions of the pathogen or any of its constituents, which stimulates the immune system and confers immunity against infections in the future. Immunizations are essential for preventing illness and safeguarding the general public's health.
The components of vaccines include pneumococcal, influenza, DTP, HPV, MMR, and COVID-19. The pneumococcal vaccine guards against infections brought on by the Streptococcus pneumoniae bacteria, which can cause sepsis, meningitis, and pneumonia. It lessens the frequency and intensity of these infections, especially in susceptible groups like young children and the elderly.
Advancements in Vaccine Technology is Expected to Boost the Patent Industry Growth
Improvements in vaccine efficacy, safety, and production speed facilitate the development of more focused and effective vaccinations. These developments improve disease prevention and control by enabling quick reactions to newly emerging pathogens. For instance, the next-generation mRNA-based flu vaccine from Moderna targets multiple influenza strains more successfully by employing cutting-edge technology. This development demonstrates how improvements in vaccine technology lead to a wider and more effective defence against infections that are constantly evolving.
There is an increase in patent activity which focuses on enhancing the performance of vaccines. There were 6,458 patents granted in 2022 which increased to 6,526 patent grants by 2023. Patents covering these technologies are crucial for companies and thus impact the vaccine patent landscape.
Increasing Incidence of Infectious Diseases is Expected to Propel Vaccine Patent Industry
The increased incidence of infectious diseases is driving the demand for vaccines as a critical tool for prevention and control. This growing need prompts ongoing vaccine development and distribution to manage and mitigate the impact of widespread infections.
The report will cover the following sections in detail:
Analysis by Indication
Analysis by Technology
Analysis by Patient Type
The breakup based on Indication includes pneumococcal, influenza, DTP, HPV, MMR, and COVID-19. The seasonal flu, which is brought on by influenza viruses and can cause serious respiratory illnesses, is prevented by the influenza vaccine. It lowers the risk of hospitalizations and complications from the flu and is updated yearly to match circulating strains.
The United States is one of the leading jurisdictions for vaccine patents, having around 217,000+ patents. The presence of big companies, well-established healthcare infrastructure, and advanced research and development activities contributes to the regional patent landscape significantly.
Among the players with vaccine patent families, new entrants have been identified, which can be either established companies or startups developing their first technology in the vaccine field. Some of the major companies mentioned in this report (a non-exhaustive list) are as follows:
This company is based in Basel, Switzerland, and was established in 1996. Leading the way in global healthcare, the company offers a wide range of products, including vaccines made by its subsidiary Novartis Vaccines. Novartis is committed to improving public health globally by using cutting-edge approaches to the prevention and treatment of infectious diseases.
This company is based in Tübingen, Germany, and was established in 2000. The company leverages its experience...
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other companies include Glaxosmithkline Biolog SA, Merck & Co Inc., Sanofi, Massachusetts Inst Technology, Inst Nat Sante Rech Med, Dana Farber Cancer Inst Inc, Regeneron Pharma, Human Genome Sciences Inc., Imperial College Innovations Ltd, among others.
The vaccine patent report provides information on the intellectual property (IP) position and strategy of key players. This report can help companies and players looking to enter or invest in this field by -
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
Scope of the Report |
Details |
Analysis by Indication |
|
Analysis by Technology |
|
Analysis by Patient Type |
|
Key Players Mentioned |
|
Geographies Covered |
|
Purchase Full Report
Datasheet
Single User License
One User
Five User License
Five Users
Corporate License
Unlimited Users
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61 448 06 17 27
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63 287899028, +63 967 048 3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84865399124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61 448 06 17 27
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63 287899028, +63 967 048 3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84865399124
Share